It is used both to treat tumours and to help clinicians determine whether they are cancerous, as well as their grade and ...

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...

The authors have declared no conflicts of interest. The patient provided informed consent for the publication of this case report. Acknowledgements: Gupta was involved in writing the original draft, ...

Well, enGene is a unique company with unique technology at actually a really unique time, right? So our technology is called the DDX pl ...